OptiBiotix Health (LON:OPTI) Share Price Passes Below 50 Day Moving Average – Here’s What Happened

OptiBiotix Health Plc (LON:OPTI – Get Free Report) shares passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 6.05 and traded as low as GBX 5.50. OptiBiotix Health shares last traded at GBX 6, with a volume of 128,541 shares trading hands.

OptiBiotix Health Stock Performance

The company has a market cap of £6.18 million, a P/E ratio of -1.56 and a beta of 1.85. The firm’s fifty day moving average is GBX 6.05 and its two-hundred day moving average is GBX 5.99.

Get OptiBiotix Health alerts:

OptiBiotix Health (LON:OPTI – Get Free Report) last posted its quarterly earnings results on Thursday, May 28th. The company reported GBX (3.84) EPS for the quarter. The business had revenue of GBX 117 million for the quarter. OptiBiotix Health had a negative net margin of 333.62% and a negative return on equity of 52.92%.

Insider Buying and Selling at OptiBiotix Health

In other OptiBiotix Health news, insider David Blain bought 158,965 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was purchased at an average price of GBX 6 per share, for a total transaction of £9,537.90. 26.79% of the stock is currently owned by company insiders.

OptiBiotix Health Company Profile

(Get Free Report)

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.

See Also

• Five stocks we like better than OptiBiotix Health
• SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
• Why Rare Earth Processing Could Be the Real 2027 Opportunity
• The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
• TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?

Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.